Seeking Alpha News
- Fathom projects Elevate and START to drive margin expansion to over 10% of transactions by year-end
- Dallas Fed Manufacturing: Mixed Perceptions In March
- Lantern Pharma outlines $15B–$20B market potential as AI-driven pipeline advances and funding needs intensify
- Lantern Pharma Inc. 2025 Q4 - Results - Earnings Call Presentation
- U.S. crude oil closes above $100 for first time since 2022 after latest Middle East threats

The weekend’s worries that the Fed may be planning the end or slowdown of QE3 translated into a lackluster market performance with little movement in any of the major indices.